Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation

PHASE3CompletedINTERVENTIONAL
Enrollment

356

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Atrial Fibrillation
Interventions
DRUG

Vernakalant Injection 20 mg/mL

Trial Locations (49)

19096

Main Line Health Heart Center, Wynnewood

23219

Medical College of Virginia, Richmond

23249

McGuire VA Medical Center, Richmond

32803

Florida Heart Institute, Orlando

33612

James Haley VA Hospital, Tampa

48910

Thoracic and Cardiovascular Institute, Lansing

54449

Marshfield Clinic, Marshfield

90073

University of California, Los Angeles

95819

Regional Cardiology Associates, Sacramento

97201

Oregon Health & Science University, Portland

02459

Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston

T2E 7C5

Heart Health Institute, Rockyview General Hospital, Calgary

T2N 4N1

University of Calgary, Calgary

T6G 2B7

University of Alberta Hospital, Edmonton

V8R 4R2

Cardiac Arrhythmia Trials, Victoria

L8L 2X2

Hamilton Health Sciences, Hamilton General Hospital, Hamilton

K1Y 4E9

Ottawa Hospitals (Civic & General), Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Emergency Medicine Research Program, Toronto

H1T 1C8

Institut de Cardiologie de Montreal, Montreal

H2L 4M1

Hopital Notre-Dame du CHUM, Montreal

H2W 1T8

CHUM-Hotel-Dieu de Montreal, Montreal

G1V 4G5

Institute de Cardiologie de Quebec, Hopital Laval, Ste Foy

J6V 2H2

Centre Hospitalier LeGardeur, Terrebonne

Unknown

Aalborg University, Aalborg

Århus Amtssygehus, Med. kardiologisk, Aarhus

Amager Hospital, Med. Center, Copenhagen

H:S Bispebjerg Hospital, Copenhagen

Helsingor Sygehus, Kardiovaskulært, Elsinore

Centralsygehuset Esbjerg Varde, Esbjerg

Fredericia Sygehus, Fredericia

Frederikssund Sygehus, Frederikssund

Glostrup Amtssygehus, Glostrup Municipality

Haderslev Sygehus, Kardiologisk Laboratorium, Haderslev

Gentofte Amtssygehus, Hellerup

Herlev Amtssygehus, Kardiologisk, Herlev

Hillerod Sygehus, Medicinsk, Hillerød

Sygehus Vendsyssel Hjorring, Hjørring

Holstebro centralsygehus, Holstebro

Horsens Sygehus, Horsens

Hvidovre Hospital, Kardiologisk, Hvidovre

Kolding Sygehus, Kardiologisk ambulatorium, Kolding

Roskilde Amts Sygehus Køge, Køge

Sygehus Fyn Svendborg, Svendborg

Universitetssjukhuset MAS, Malmo

Universitetssjukhuset, Molndal, Mölndal

Universityetssjukhuset, Orebro, Örebro

Danderyds sjukhus, Stockholm

Akademiska Sjukhuset, Uppsala, Uppsala

Centrallasarettet, Vasteras, Västerås

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Astellas Pharma US, Inc.

INDUSTRY

lead

Advanz Pharma

INDUSTRY

NCT00468767 - Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter